Đang chuẩn bị liên kết để tải về tài liệu:
Báo cáo khoa học: "Serum estradiol should be monitored not only during the peri-menopausal period but also the post-menopausal period at the time of aromatase inhibitor administration"

Tuyển tập báo cáo các nghiên cứu khoa học quốc tế ngành y học dành cho các bạn tham khảo đề tài: Serum estradiol should be monitored not only during the peri-menopausal period but also the post-menopausal period at the time of aromatase inhibitor administration | BioMed Central World Journal of Surgical Oncology Research Relapse in resected lung cancer revisited does intensified follow up really matter A prospective study Dragan Subotic 1 Dragan Mandaric1 Gordana Radosavljevic1 Jelena Stojsic1 Milan Gajic2 and Maja Ercegovac1 Open Access Address Institute for Lung Diseases Clinical Center of Serbia Belgrade Serbia and institute for Medical Statistics Faculty of Medicine Belgrade Serbia Email Dragan Subotic - vilusi@yubc.net Dragan Mandaric - dmandaric@googlemail.com Gordana Radosavljevic - milena@drenik.net Jelena Stojsic - grudhir@yubc.net Milan Gajic - milgaj@med.bg.ac.rs Maja Ercegovac - majaerce@verat.net Corresponding author Published 12 November 2009 Received 19 July 2009 __ rr. inAO - .0-7 j.unnoznj-moimov Accepted 12 November 2009 World Journal of Surgical Oncology 2009 7 87 doi 10.1186 1477-7819-7-87 This article is available from http www.wjso.com content 7 1 87 2009 Subotic et al licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License http creativecommons.org licenses by 2.0 which permits unrestricted use distribution and reproduction in any medium provided the original work is properly cited. Abstract Background beside the well known predominance of distant vs. loco-regional relapse several aspects of the relapse pattern still have not been fully elucidated. Methods prospective controlled study on 88 patients operated for non-small cell lung cancer NSCLC in a 15 months period. Stage IIIA existed in 35 39.8 patients whilst stages IB IIA and IIB existed in 10.2 4.5 and 45.5 patients respectively. Inclusion criteria stage I-IIIA complete resection systematic lymphadenectomy with at least 6 lymph node groups examined no neoadjuvant therapy exact data of all aspects of relapse exact data about the outcome of the treatment. Results postoperative lung cancer relapse occurred in 50 56.8 patients. Locoregional distant and both types of relapse